Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
- Status
- COMPLETED
- Phase
- PHASE3